Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 04, 2023

SELL
$71.62 - $86.62 $2.13 Million - $2.58 Million
-29,780 Reduced 43.43%
38,796 $2.88 Million
Q4 2022

Feb 06, 2023

BUY
$80.67 - $352.29 $4.15 Million - $18.1 Million
51,408 Added 299.44%
68,576 $5.68 Million
Q3 2022

Nov 02, 2022

BUY
$282.54 - $391.85 $1.51 Million - $2.09 Million
5,337 Added 45.11%
17,168 $4.88 Million
Q2 2022

Aug 05, 2022

BUY
$322.67 - $449.65 $1.07 Million - $1.49 Million
3,320 Added 39.01%
11,831 $4.1 Million
Q1 2022

May 06, 2022

BUY
$353.85 - $487.79 $70,770 - $97,558
200 Added 2.41%
8,511 $3.69 Million
Q4 2021

Feb 03, 2022

BUY
$456.15 - $525.06 $99,440 - $114,463
218 Added 2.69%
8,311 $4.3 Million
Q3 2021

Nov 08, 2021

BUY
$444.87 - $538.88 $645,506 - $781,914
1,451 Added 21.85%
8,093 $3.92 Million
Q2 2021

Aug 05, 2021

BUY
$387.35 - $450.26 $283,927 - $330,040
733 Added 12.4%
6,642 $2.99 Million
Q1 2021

May 05, 2021

BUY
$314.62 - $411.0 $336,643 - $439,770
1,070 Added 22.11%
5,909 $2.26 Million
Q4 2020

Feb 04, 2021

SELL
$246.9 - $321.87 $94,562 - $123,276
-383 Reduced 7.33%
4,839 $1.54 Million
Q3 2020

Nov 02, 2020

BUY
$232.22 - $282.96 $25,079 - $30,559
108 Added 2.11%
5,222 $1.29 Million
Q2 2020

Aug 05, 2020

BUY
$185.43 - $279.56 $50,993 - $76,879
275 Added 5.68%
5,114 $1.35 Million
Q4 2019

Feb 07, 2020

SELL
$189.68 - $222.09 $1.21 Million - $1.42 Million
-6,373 Reduced 56.84%
4,839 $1.06 Million
Q2 2019

Jul 29, 2019

SELL
$188.72 - $215.43 $307,613 - $351,150
-1,630 Reduced 12.69%
11,212 $2.34 Million
Q1 2019

Apr 25, 2019

BUY
$136.09 - $200.44 $180,999 - $266,585
1,330 Added 11.55%
12,842 $2.55 Million
Q3 2018

Nov 05, 2018

BUY
$147.44 - $204.11 $112,349 - $155,531
762 Added 7.09%
11,512 $2.35 Million
Q1 2018

Apr 27, 2018

SELL
$131.46 - $151.04 $4.92 Million - $5.66 Million
-37,458 Reduced 77.7%
10,750 $1.62 Million
Q2 2017

Aug 09, 2017

BUY
N/A
48,208
48,208 $5.66 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.8B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.